We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$405M
AUM Growth
-$137M
Cap. Flow
-$131M
Cap. Flow %
-32.46%
Top 10 Hldgs %
79.23%
Holding
289
New
27
Increased
4
Reduced
8
Closed
245

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$55.6M
2
HYPR icon
Hyperfine
HYPR
+$17.2M
3
ADC icon
Agree Realty
ADC
+$8.67M
4
DCGO icon
DocGo
DCGO
+$6.96M
5
CMPX icon
Compass Therapeutics
CMPX
+$6.63M

Top Sells

Rank Stock Value
1
MRVI icon
Maravai LifeSciences
MRVI
+$9.08M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$7.86M
3
ML
MoneyLion Inc.
ML
+$6.77M
4
RBC icon
RBC Bearings
RBC
+$5.3M
5
BCAB icon
BioAtla
BCAB
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 24.5%
2 Financials 4.73%
3 Real Estate 2.66%
4 Materials 1.45%
5 Consumer Staples 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTMDW
176
DELISTED
Biote Corp. Warrant
BTMDW
– –
-124,999
Closed -$101K
CORS.WS
177
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
– –
-83,331
Closed -$63K
CORS
178
DELISTED
Corsair Partnering Corporation
CORS
– –
-249,993
Closed -$2.46M
ZT
179
DELISTED
Zimmer Energy Transition Acquisition Corp. Class A Common Stock
ZT
– –
-199,992
Closed -$1.95M
ZTAQW
180
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
– –
-66,664
Closed -$60K
WRAC.WS
181
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
– –
-99,999
Closed -$50K
CYXT
182
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
– –
-500,000
Closed -$4.63M
ATIP.WS
183
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
– –
-49,999
Closed -$33K
SNRH
184
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
– –
-250,000
Closed -$2.44M
SNRHW
185
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
– –
-499,999
Closed -$355K
RONI.WS
186
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
– –
-24,998
Closed -$40K
PHGE.WS
187
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
– –
-87,307
Closed -$29K
PNTM.WS
188
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
– –
-33,332
Closed -$24K
PSPC
189
DELISTED
Post Holdings Partnering Corporation
PSPC
– –
-149,997
Closed -$1.45M
SGTX
190
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
– –
-24,420
Closed -$1.79M
VLATW
191
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
– –
-33,330
Closed -$27K
VLAT
192
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
– –
-99,990
Closed -$975K
SKYAW
193
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
– –
-133,332
Closed -$100K
SKYA
194
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
– –
-200,000
Closed -$1.94M
EUCRW
195
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
– –
-99,998
Closed -$71K
ML
196
DELISTED
MoneyLion Inc.
ML
– –
-33,333
Closed -$6.77M
ATCX
197
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
– –
-40,103
Closed -$408K
PEARW
198
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
– –
-33,332
Closed -$32K
MSDA
199
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
– –
-228,378
Closed -$1.91M
STRE
200
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
– –
-99,995
Closed -$977K
6 7
8
9 10

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Monashee Investment Management held 289 positions worth $405M, down 25% from $542M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Monashee Investment Management withdrew a net $131M in Q4 2021, closing 245 positions and reducing 8 holdings. Its most notable exit was Maravai LifeSciences, an estimated $9.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Monashee Investment Management opened a new position in Hyperfine worth $15.7M.

  • Monashee Investment Management's largest Q4 2021 buy was Hyperfine: 2,171,395 shares worth $15.7M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q4 2021, an estimated $55.6M increase.
  • Monashee Investment Management's biggest Q4 2021 reduction was SomaLogic, Inc. Class A Common Stock, cutting an estimated $7.86M.
  • Monashee Investment Management fully exited Maravai LifeSciences in Q4 2021, selling an estimated $9.08M.
  • Monashee Investment Management's ten largest holdings make up 79% of its $405M portfolio in Q4 2021.
  • Monashee Investment Management opened 27 new positions and closed 245 in Q4 2021.
  • Monashee Investment Management's portfolio value fell 25% quarter-over-quarter to $405M.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.